2007
DOI: 10.1080/08923970701512304
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Skin Sensitizers on Inducible Nitric Oxide Synthase Expression and Nitric Oxide Production in Skin Dendritic Cells: Role of Different Immunosuppressive Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
4
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 60 publications
1
4
0
Order By: Relevance
“…57 Cruz and colleagues demonstrated that dendritic cell-derived NO directly triggers skin inflammation after applications of contact sensitizers and irritants. 58 These reports, along with our findings, support that NO from iNOS-positive LCs mediates skin immunoreactions during the development of pain behavior in db/db mice.…”
supporting
confidence: 87%
“…57 Cruz and colleagues demonstrated that dendritic cell-derived NO directly triggers skin inflammation after applications of contact sensitizers and irritants. 58 These reports, along with our findings, support that NO from iNOS-positive LCs mediates skin immunoreactions during the development of pain behavior in db/db mice.…”
supporting
confidence: 87%
“…On the other hand, the PI3K inhibitor LY294002 induced an increase in the Trx-1 protein levels by 98.1% (*P < 0.05), when compared with LPS alone. Neither dexamethasone nor cyclosporin A, immunosuppressors that inhibit the transcription factor NF-B in FSDC, as previously demonstrated by us [17,63], had an eVect on Trx-1 protein levels in LPS-stimulated cells.…”
Section: Intracellular Signalling Pathways Involved In the Increase Omentioning
confidence: 54%
“…In addition, the eVect of the immunomodulators such as dexamethasone (5 M) and cyclosporin A (1 M) was also evaluated on Trx-1 protein expression induced by LPS. Dexamethasone and cyclosporin A are immunosuppressors that inhibit the transcription factor NF-B in FSDC, as previously demonstrated by us [17,63].…”
Section: Chemical Treatmentmentioning
confidence: 70%
“…It has generally been believed that iNOS is involved in CHS as a producer of NO and a trigger of inflammatory responses (Cals-Grierson and Ormerod, 2004) reported that iNOS and NO were produced in human skin subjected to positive patch tests to contact allergens (Cruz et al, 2007;Ormerod et al, 1997) and to the irritant sodium lauryl sulfate; nevertheless, it remains controversial whether iNOS is inhibitory or augmentative in CHS (Ross and ReskeKunz, 2001). It has also been reported that an iNOS inhibitor exerted a suppressive effect on the CHS response to 2,4,6-trinitrochlorobenzene (TNCB) (Musoh et al, 1998), although this effect was limited to the first few hours of the response, and neither NO production, NO-expressing cells, nor NOS isoenzymes were identified.…”
Section: Discussionmentioning
confidence: 97%